Effectiveness of a Multidisciplinary Treatment for Patients With Chronic Low Back Pain

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Barcelona

About this trial

PAINDOC is a treatment program that includes 4 disciplines that, separately, have demonstrated their effectiveness in the treatment of chronic low back pain: education in pain neuroscience, therapeutic education (Empowered Relief®), psychotherapy based on cognitive-behavioral therapy and therapeutic exercise.

The primary objective of the study is to evaluate the effectiveness of the PAINDOC multidisciplinary treatment program in reducing pain intensity and improving quality of life in persons with chronic low back pain referred to the pain unit of the Hospital Clinic of Barcelona, compared to usual care treatment.

As secondary objectives, the present study aims to evaluate the effect of the PAINDOC program on:

* The reduction of pain-related disability. * The reduction of pain catastrophizing. * The improvement in perceived social support. * The improvement in perceived autonomy (self-efficacy). * The reduction of analgesic, anti-inflammatory and adjuvant analgesic medication.

The main questions it aims to answer are:

* Is the proposed multidisciplinary treatment effective in improving pain-related outcomes? * Is the proposed multidisciplinary treatment effective in reducing analgesic medication?

Participants will receive either usual care (pharmacological control) or the PAINDOC program, which consists of 7 multidisciplinary sessions within 2 months. There will be one therapeutic education session called Empowered Relief®, 2 pain neuroscience education sessions, one pain psychology session and 3 therapeutic education sessions. Besides, participants will be assessed using written questionnaires before treatment, at 3 months and at 6 months.

Researchers will assess the effectiveness of the multidisciplinary treatment group comparing both groups to see if there is any difference in several pain-related outcomes.

Eligibility criteria

Qualifiers

Patients over 18 years of age.

Patients with primary chronic low back pain (non-specific chronic low back pain) of axial predominance.

Experiencing pain at least 50% of the time over the last 6 months.

Average weekly pain intensity equal or greater than 4 out of 10 on a verbal numerical scale.

Disqualifiers

Inflammatory low back pain.

History of cancer in the last 5 years.

Unexplained and unintentional weight loss of 10 Kg or more over the preceding 12-month period.

Lack of control of bowel and bladder function (cauda equina).

Trial design

Treatments tested in this trial

  • Multidisciplinary and multimodal intervention
  • Usual Care

Treatment groups

62 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Barcelona

Lead sponsor

Hospital Clinic of Barcelona

Collaborator